Cindy Liu, PHARMD
Pharmacist · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Cindy Liu’s office at (408) 530-2845 to ask if they take your plan before you enroll.
California Medical Board record
Licence G72450 · Cancelled
Licence status: Cancelled · since 1991 · University of California, Los Angeles School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$66,577
Pharmacies billed $66,577 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 549) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
271 generic and 204 brand-name prescriptions · $66,577 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humulin R | 43 | $8,689 | $202 |
| Humulin N | 48 | $8,022 | $167 |
| Jardiance | 13 | $6,709 | $516 |
| Humulin 70/30 Kwikpen | 13 | $3,822 | $294 |
| Insulin Glargine-Yfgn | 29 | $3,185 | $110 |
See all 15 drugs
| Humulin R | 43 | $8,689 | $202 |
| Humulin N | 48 | $8,022 | $167 |
| Jardiance | 13 | $6,709 | $516 |
| Humulin 70/30 Kwikpen | 13 | $3,822 | $294 |
| Insulin Glargine-Yfgn | 29 | $3,185 | $110 |
| Humulin N Kwikpen | 17 | $1,742 | $102 |
| Glipizide | 60 | $808 | $13 |
| Metformin | 46 | $705 | $15 |
| Atorvastatin | 58 | $678 | $12 |
| Ultra-Fine Nano Pen Needle | 22 | $578 | $26 |
| Glipizide Er | 14 | $563 | $40 |
| Veo Insulin | 23 | $552 | $24 |
| Metformin Hcl Er | 43 | $409 | $10 |
| Veo Insulin | 11 | $247 | $22 |
| Simvastatin | 11 | $128 | $12 |
Year by year
| 2024 | 549 | 114 | 0% (0) | 37% | $66,577 |
| 2023 | 545 | 111 | 0% (0) | 35% | $66,456 |
| 2022 | 499 | 97 | 0% (0) | 37% | $62,293 |
| 2021 | 493 | 111 | 0% (0) | 40% | $62,502 |
| 2020 | 452 | 116 | 0% (0) | 43% | $57,534 |
| 2019 | 407 | 99 | 0% (0) | 41% | $35,519 |
| 2018 | 365 | 100 | 0% (0) | 39% | $35,623 |
| 2017 | 364 | 121 | 0% (0) | 32% | $22,632 |
| 2016 | 260 | 114 | 0% (0) | None | $11,196 |
| 2015 | 48 | 43 | 0% (0) | 35% | $3,664 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Humulin R | 50 | $10,230 | $205 |
| Humulin N | 50 | $8,118 | $162 |
| Humulin N Kwikpen | 32 | $3,079 | $96 |
| Humulin 70/30 Kwikpen | 12 | $2,292 | $191 |
| Veo Insulin | 35 | $895 | $26 |
| Glipizide | 51 | $863 | $17 |
| Metformin | 50 | $789 | $16 |
| Atorvastatin | 46 | $742 | $16 |
| Ultra-Fine Nano Pen Needle | 27 | $592 | $22 |
| Glipizide Er | 15 | $544 | $36 |
| Veo Insulin | 18 | $455 | $25 |
| Metformin Hcl Er | 36 | $347 | $10 |
| Simvastatin | 13 | $152 | $12 |
2022: 13 drugs
| Humulin N | 55 | $9,669 | $176 |
| Humulin R | 41 | $9,401 | $229 |
| Humulin 70/30 Kwikpen | 13 | $4,384 | $337 |
| Humulin N Kwikpen | 22 | $2,352 | $107 |
| Glipizide | 46 | $806 | $18 |
| Veo Insulin | 36 | $784 | $22 |
| Metformin Hcl Er | 54 | $542 | $10 |
| Glipizide Er | 13 | $541 | $42 |
| Ultra-Fine Nano Pen Needle | 20 | $527 | $26 |
| Veo Insulin | 18 | $513 | $28 |
| Metformin | 32 | $463 | $14 |
| Pioglitazone | 13 | $452 | $35 |
| Atorvastatin | 27 | $392 | $15 |
2021: 15 drugs
| Humulin N | 80 | $14,330 | $179 |
| Humulin R | 42 | $7,755 | $185 |
| Jardiance | 12 | $7,428 | $619 |
| Lantus | 11 | $7,304 | $664 |
| Humulin 70-30 | 11 | $3,185 | $290 |
| Humalog | 11 | $2,912 | $265 |
| Humulin N Kwikpen | 11 | $1,530 | $139 |
| Glipizide | 53 | $879 | $17 |
| Veo Insulin | 30 | $710 | $24 |
| Veo Insulin | 16 | $500 | $31 |
| Metformin Hcl Er | 50 | $490 | $10 |
| Ultra-Fine Nano Pen Needle | 14 | $398 | $28 |
| Metformin | 29 | $378 | $13 |
| Atorvastatin | 30 | $363 | $12 |
| Simvastatin | 14 | $163 | $12 |
2020: 14 drugs
| Humulin N | 89 | $16,674 | $187 |
| Lantus | 12 | $10,658 | $888 |
| Humulin R | 41 | $8,490 | $207 |
| Humulin N Kwikpen | 19 | $3,578 | $188 |
| Glipizide | 48 | $659 | $14 |
| Veo Insulin | 35 | $636 | $18 |
| Atorvastatin | 27 | $420 | $16 |
| Pioglitazone | 18 | $348 | $19 |
| Ultra-Fine Nano Pen Needle | 12 | $348 | $29 |
| Veo Insulin | 13 | $262 | $20 |
| Metformin Hcl Er | 27 | $250 | $9 |
| Lisinopril | 20 | $243 | $12 |
| Metformin | 19 | $242 | $13 |
| Simvastatin | 14 | $170 | $12 |
2019: 8 drugs
| Humulin N | 87 | $16,060 | $185 |
| Humulin R | 50 | $8,458 | $169 |
| Atorvastatin | 35 | $901 | $26 |
| Glipizide | 56 | $687 | $12 |
| Metformin | 40 | $546 | $14 |
| Veo Insulin | 21 | $431 | $21 |
| Metformin Hcl Er | 20 | $209 | $10 |
| Lisinopril | 18 | $197 | $11 |
2018: 8 drugs
| Humulin N | 75 | $14,952 | $199 |
| Humulin R | 30 | $4,818 | $161 |
| Glipizide | 60 | $1,452 | $24 |
| Veo Insulin | 38 | $674 | $18 |
| Atorvastatin | 21 | $648 | $31 |
| Metformin | 33 | $476 | $14 |
| Metformin Hcl Er | 28 | $454 | $16 |
| Lisinopril | 11 | $122 | $11 |
2017: 8 drugs
| Humulin N | 65 | $9,812 | $151 |
| Humulin R | 22 | $2,900 | $132 |
| Warfarin | 95 | $1,351 | $14 |
| Glipizide | 34 | $917 | $27 |
| Insulin | 33 | $635 | $19 |
| Metformin | 38 | $490 | $13 |
| Atorvastatin | 16 | $401 | $25 |
| Metformin Hcl Er | 18 | $272 | $15 |
2016: 2 drugs
| Lovenox | 32 | $6,222 | $194 |
| Warfarin | 193 | $2,854 | $15 |
2015: 2 drugs
| Lovenox | 17 | $3,193 | $188 |
| Warfarin | 31 | $471 | $15 |
Professional record
- NPI
- 1639585656
- Licence
- AZ S020912, CA 72450, MD 22309, UT 8668394-1701California G72450: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2014-07-10
- NPI last updated
- 2021-12-23
- NPI record certified
- 2021-12-23
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.